AR072561A1 - Complejo de inclusion de clorhidrato de raloxifeno y b- ciclodextrina - Google Patents
Complejo de inclusion de clorhidrato de raloxifeno y b- ciclodextrinaInfo
- Publication number
- AR072561A1 AR072561A1 ARP090102669A ARP090102669A AR072561A1 AR 072561 A1 AR072561 A1 AR 072561A1 AR P090102669 A ARP090102669 A AR P090102669A AR P090102669 A ARP090102669 A AR P090102669A AR 072561 A1 AR072561 A1 AR 072561A1
- Authority
- AR
- Argentina
- Prior art keywords
- inclusion complex
- raloxifen
- chlorhydrate
- cyclodextrine
- complex inclusion
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Se describe un complejo de inclusion de clorhidrato de raloxifeno y beta-ciclodextrina en la fase solida, que tiene un espectro de difraccion de rayos X de polvo. A su vez, la solicitud se relaciona a un proceso de obtencion del complejo de inclusion de clorhidrato de raloxifeno y beta-ciclodextrina de la presente solicitud. El complejo de inclusion se emplea como producto farmacéutico en el tratamiento de la osteoporosis y específicamente en la osteoporosis postmenopáusica. Reivindicacion 4: El complejo de inclusion segun cualquiera de las reivindicaciones 1 a 3, caracterizado porque comprende 57 picos en los siguientes grados de difraccion e intensidad relativa, segun se muestra en la tabla (1).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09425196A EP2253627A1 (en) | 2009-05-21 | 2009-05-21 | Inclusion complex of raloxifene hydrochloride and beta-cyclodextrin. |
Publications (1)
Publication Number | Publication Date |
---|---|
AR072561A1 true AR072561A1 (es) | 2010-09-08 |
Family
ID=41011803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP090102669A AR072561A1 (es) | 2009-05-21 | 2009-07-14 | Complejo de inclusion de clorhidrato de raloxifeno y b- ciclodextrina |
Country Status (15)
Country | Link |
---|---|
US (1) | US20100298265A1 (es) |
EP (1) | EP2253627A1 (es) |
JP (1) | JP2010270100A (es) |
KR (1) | KR20100126146A (es) |
CN (1) | CN101890171A (es) |
AR (1) | AR072561A1 (es) |
AU (1) | AU2009202887A1 (es) |
BR (1) | BRPI0902387A2 (es) |
CA (1) | CA2671921A1 (es) |
IL (1) | IL199883A0 (es) |
MX (1) | MX2009007785A (es) |
NZ (1) | NZ578451A (es) |
RU (1) | RU2009127394A (es) |
TW (1) | TW201041878A (es) |
ZA (1) | ZA200905145B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102198274B (zh) * | 2011-03-30 | 2013-04-24 | 天津红日药业股份有限公司 | 雷洛昔芬的环糊精包合物及其制剂的制备方法 |
ITMI20121821A1 (it) * | 2012-10-25 | 2014-04-26 | Erregierre Spa | Composizione farmaceutica solubile in acqua a base di un sale di raloxifene |
KR102583356B1 (ko) * | 2017-01-09 | 2023-09-26 | 에스씨아이팜 에스에이알엘 | 수용성 포스콜린의 신규 제조 방법 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2135176C1 (ru) | 1993-12-14 | 1999-08-27 | Эли Лилли Энд Компани | Водорастворенный комплекс включения соединений бензотиофена с водорастворимым циклодекстрином, способ его получения и фармацевтическая композиция |
US6713494B1 (en) * | 1996-08-28 | 2004-03-30 | Eli Lilly And Company | Amorphous benzothiophenes, methods of preparation and methods of use |
US20030130316A1 (en) * | 2000-03-20 | 2003-07-10 | Steiner Mitchell S. | Method for chemoprevention of prostate cancer |
CN1210079C (zh) * | 2001-04-25 | 2005-07-13 | 上海市计划生育科学研究所 | 阴道环制剂及其应用 |
US20060105045A1 (en) | 2004-11-08 | 2006-05-18 | Buchanan Charles M | Cyclodextrin solubilizers for liquid and semi-solid formulations |
US20060270641A1 (en) * | 2005-05-31 | 2006-11-30 | Steiner Mitchell S | Method for chemoprevention of prostate cancer |
EP2271320A4 (en) * | 2008-04-02 | 2011-05-18 | Reddys Lab Ltd Dr | PHARMACEUTICAL RALOXIFY FORMULATIONS |
-
2009
- 2009-05-21 EP EP09425196A patent/EP2253627A1/en not_active Withdrawn
- 2009-07-14 AR ARP090102669A patent/AR072561A1/es unknown
- 2009-07-15 BR BRPI0902387-9A patent/BRPI0902387A2/pt not_active Application Discontinuation
- 2009-07-15 US US12/460,236 patent/US20100298265A1/en not_active Abandoned
- 2009-07-15 IL IL199883A patent/IL199883A0/en unknown
- 2009-07-15 CA CA2671921A patent/CA2671921A1/en not_active Abandoned
- 2009-07-16 AU AU2009202887A patent/AU2009202887A1/en not_active Abandoned
- 2009-07-16 RU RU2009127394/04A patent/RU2009127394A/ru not_active Application Discontinuation
- 2009-07-16 NZ NZ578451A patent/NZ578451A/en not_active IP Right Cessation
- 2009-07-16 TW TW098124060A patent/TW201041878A/zh unknown
- 2009-07-16 KR KR1020090064925A patent/KR20100126146A/ko not_active Application Discontinuation
- 2009-07-17 JP JP2009169465A patent/JP2010270100A/ja not_active Withdrawn
- 2009-07-17 CN CN2009101591633A patent/CN101890171A/zh active Pending
- 2009-07-21 MX MX2009007785A patent/MX2009007785A/es not_active Application Discontinuation
- 2009-07-22 ZA ZA200905145A patent/ZA200905145B/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20100298265A1 (en) | 2010-11-25 |
MX2009007785A (es) | 2010-11-22 |
NZ578451A (en) | 2010-09-30 |
CA2671921A1 (en) | 2010-11-21 |
ZA200905145B (en) | 2010-04-28 |
BRPI0902387A2 (pt) | 2011-02-01 |
JP2010270100A (ja) | 2010-12-02 |
RU2009127394A (ru) | 2011-01-27 |
TW201041878A (en) | 2010-12-01 |
KR20100126146A (ko) | 2010-12-01 |
CN101890171A (zh) | 2010-11-24 |
EP2253627A1 (en) | 2010-11-24 |
AU2009202887A1 (en) | 2010-12-09 |
IL199883A0 (en) | 2010-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA033266B1 (ru) | Гидроксисложноэфирные производные, способ их получения и фармацевтические композиции, содержащие их | |
NZ629996A (en) | 2’- substituted carba-nucleoside analogs for antiviral treatment | |
ZA201504665B (en) | Processes and apparatus for producing nanocellulose, and compositions and products produced therefrom | |
JO3674B1 (ar) | مشتقات ثنائية الحلقة جديدة، عملية لتحضيرها وتركيبات صيدلية تحتوي عليها | |
BR112015011112A2 (pt) | composto oligomérico, oligômero, composição farmacêutica, uso do composto oligomérico, método de síntese de um composto oligomérico e método de tratamento de uma doença. | |
CL2019000115A1 (es) | Compuestos y métodos para la modulación de smn2. | |
CL2015001437A1 (es) | Derivados de pirimidin-2,4-diamina para el tratamiento de cancer | |
CY1120204T1 (el) | Αμορφη στερεα διασπορα για χρηση σε θεραπεια καρκινου του εγκεφαλο | |
GEP201706624B (en) | Triazolopyrazine as brd4 inhibitors and usage thereof for cancer treatment | |
GB201209613D0 (en) | New compounds | |
BR112015001782A2 (pt) | método para produzir uma composição para o tratamento de um dente lesionado | |
CL2014001838A1 (es) | Compuestos derivados de fluormetil-5,6-dihidro-4h-[1,3]oxazin-2-ilamina, como inhibidores de la bace1; su proceso de obtencion; composicion farmaceutica que los contiene; y su uso para el tratamiento terapeutico y/o profilactico de la enfermedad de alzheimer, esclerosis lateral amiotrofica, cancer, enfermedades cardiovasculares y enfermedades gastrointestinales, entre otras. | |
DOP2015000215A (es) | Sal de abexinostato novedosa, forma cristalina relacionada, método de preparación de esta y las composiciones farmacéuticas que la contienen | |
BR112015028565A2 (pt) | Processos de pré-condicionamento de material e de produção de um produto | |
CY1118198T1 (el) | Παραγωγα παντοθενικου για την αντιμετωπιση νευρολογικων διαταραχων | |
AR072561A1 (es) | Complejo de inclusion de clorhidrato de raloxifeno y b- ciclodextrina | |
GT201600232A (es) | Derivados de diheterociclo enlazado a cicloalquilo | |
AR128635A2 (es) | Formulación de flumioxazina, composición herbicida que lo comprende y método para producir un herbicida | |
MX364528B (es) | Witanólidos útiles para el tratamiento de enfermedades neurodegenerativas. | |
MX2018004696A (es) | Analogos de epotilona, metodos de sintesis, metodos de tratamiento y conjugados con farmacos de los mismos. | |
MX2018015269A (es) | Derivados de tailanstatina a, metodos de tratamiento y metodos de sintesis de los mismos. | |
PH12018500014A1 (en) | Total synthesis of shishijimicin a and analogs thereof | |
MX2016004094A (es) | Composicion farmaceutica que comprende capecitabina y ciclofosfamida. | |
IN2013MU02576A (es) | ||
CR20150545A (es) | Agentes quelantes de precursores de producto final de glicación avanzada (age) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |